1,025 followers
Ever-suni no demuestra no inf frente a suni-ever en CRm http://t.co/9WEBXz9Q6O
Ever-suni no demuestra no inf frente a suni-ever en CRm http://t.co/9WEBXz9Q6O
RCT supports standard paradigm sunitinib 1st line/ everolimus 2nd line in Metastatic Renal Cell Carcinoma http://t.co/HBtMgsbgv6 via @ASCO
Trial Comparing 1st-Line Everolimus and 2nd-Line Sunitinib Versus 1st-Line Sunitinib and 2nd-Line Everolimus in mRCC http://t.co/rvRQoTQXYz
Trial Comparing 1st-Line Everolimus and 2nd-Line Sunitinib Versus 1st-Line Sunitinib and 2nd-Line Everolimus in mRCC http://t.co/rvRQoTQXYz